Generation of Induced Pluripotent Stem Cells from Asian Patients with Chronic Neurodegenerative Diseases
-
- LUO Yumei
- The Third Affiliated Hospital of Guangzhou Medical University, Guangdong, China Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
-
- FAN Yong
- The Third Affiliated Hospital of Guangzhou Medical University, Guangdong, China Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
-
- CHEN Xinjie
- The Third Affiliated Hospital of Guangzhou Medical University, Guangdong, China Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
-
- YU Bolan
- The Third Affiliated Hospital of Guangzhou Medical University, Guangdong, China Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
-
- YUE Lei
- The Third Affiliated Hospital of Guangzhou Medical University, Guangdong, China Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
-
- WANG Ding
- The Third Affiliated Hospital of Guangzhou Medical University, Guangdong, China Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
-
- LI Qing
- The Third Affiliated Hospital of Guangzhou Medical University, Guangdong, China Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
-
- CHEN Yaoyong
- The Third Affiliated Hospital of Guangzhou Medical University, Guangdong, China Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
-
- SUN Xiaofang
- The Third Affiliated Hospital of Guangzhou Medical University, Guangdong, China Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
この論文をさがす
抄録
Induced pluripotent stem (iPS) cells derived from disease patients are an invaluable resource for biomedical research and may provide a source for replacement therapies. In this study, we have generated iPS cells from Asian patients with chronic degenerative diseases of the nervous system, including spinal muscular atrophy (SMA), Parkinson disease (PD) and amyotrophic lateral sclerosis (ALS) by transduction with four factors (KLF4, SOX2, OCT4 and c-MYC). All of the iPS cells showed pluripotency similar to that of human embryonic stem cells (hESCs) and were able to differentiate into various somatic cell types in vitro and in vivo. Furthermore, the iPS cells also can be committed to differentiate into neural cells, the cell type that is affected in chronic degenerative diseases. Therefore, the patient-specific iPS cells we generated offer a cellular model in which to investigate disease mechanisms, discover and test novel drugs and develop new therapies for chronic neurodegenerative diseases.
収録刊行物
-
- Journal of Reproduction and Development
-
Journal of Reproduction and Development 58 (5), 515-521, 2012
公益社団法人 日本繁殖生物学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282681312901504
-
- NII論文ID
- 10031123294
-
- NII書誌ID
- AA10936678
-
- COI
- 1:STN:280:DC%2BC38npsFSqsw%3D%3D
-
- ISSN
- 13484400
- 09168818
-
- NDL書誌ID
- 024025976
-
- PubMed
- 22673189
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可